SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
October 17, 2025
 · 
7 min read
Press Releases
Sona Nanotech To Host Investor Webinar To Discuss Clinical Study
October 17, 2025
 · 
2 min read
Press Releases
PharmaTher Applauds FDA’s Commissioner’s National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale
October 17, 2025
 · 
8 min read
Press Releases
OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
October 17, 2025
 · 
5 min read
Press Releases
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
October 16, 2025
 · 
4 min read
Press Releases
PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson’s Disease
October 16, 2025
 · 
6 min read
Press Releases
Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
October 16, 2025
 · 
11 min read
Press Releases
Marc Walther, President and CEO of Impact Fusion Files a Patent Pending Related to Artificial Insemination of Mammals
October 15, 2025
 · 
10 min read
Press Releases
Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025
October 15, 2025
 · 
1 min read
Press Releases
PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings
October 15, 2025
 · 
7 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us